nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—CYP3A4—Esomeprazole—Barrett's esophagus	0.146	0.629	CbGbCtD
Orlistat—CYP3A4—Omeprazole—Barrett's esophagus	0.0863	0.371	CbGbCtD
Orlistat—PNLIP—exocrine gland—Barrett's esophagus	0.0445	0.404	CbGeAlD
Orlistat—LIPF—digestive system—Barrett's esophagus	0.0415	0.377	CbGeAlD
Orlistat—Faeces discoloured—Omeprazole—Barrett's esophagus	0.0257	0.0453	CcSEcCtD
Orlistat—Faeces discoloured—Esomeprazole—Barrett's esophagus	0.0257	0.0453	CcSEcCtD
Orlistat—Anal pruritus—Omeprazole—Barrett's esophagus	0.0213	0.0375	CcSEcCtD
Orlistat—Anal pruritus—Esomeprazole—Barrett's esophagus	0.0213	0.0375	CcSEcCtD
Orlistat—PNLIP—digestive system—Barrett's esophagus	0.0147	0.134	CbGeAlD
Orlistat—PLA2G7—Peptide hormone metabolism—CDX2—Barrett's esophagus	0.012	0.133	CbGpPWpGaD
Orlistat—Pruritus genital—Omeprazole—Barrett's esophagus	0.0107	0.0188	CcSEcCtD
Orlistat—Pruritus genital—Esomeprazole—Barrett's esophagus	0.0107	0.0188	CcSEcCtD
Orlistat—Anorectal discomfort—Esomeprazole—Barrett's esophagus	0.00815	0.0144	CcSEcCtD
Orlistat—Anorectal discomfort—Omeprazole—Barrett's esophagus	0.00815	0.0144	CcSEcCtD
Orlistat—Fracture—Omeprazole—Barrett's esophagus	0.00767	0.0135	CcSEcCtD
Orlistat—Multiple fractures—Esomeprazole—Barrett's esophagus	0.00767	0.0135	CcSEcCtD
Orlistat—Fracture—Esomeprazole—Barrett's esophagus	0.00767	0.0135	CcSEcCtD
Orlistat—Multiple fractures—Omeprazole—Barrett's esophagus	0.00767	0.0135	CcSEcCtD
Orlistat—PLA2G4A—smooth muscle tissue—Barrett's esophagus	0.00752	0.0683	CbGeAlD
Orlistat—Dysmenorrhoea—Esomeprazole—Barrett's esophagus	0.0049	0.00864	CcSEcCtD
Orlistat—Arthropathy—Esomeprazole—Barrett's esophagus	0.0049	0.00864	CcSEcCtD
Orlistat—Dysmenorrhoea—Omeprazole—Barrett's esophagus	0.0049	0.00864	CcSEcCtD
Orlistat—Arthropathy—Omeprazole—Barrett's esophagus	0.0049	0.00864	CcSEcCtD
Orlistat—Vaginal inflammation—Omeprazole—Barrett's esophagus	0.00446	0.00785	CcSEcCtD
Orlistat—Vaginal inflammation—Esomeprazole—Barrett's esophagus	0.00446	0.00785	CcSEcCtD
Orlistat—Eructation—Esomeprazole—Barrett's esophagus	0.00438	0.00772	CcSEcCtD
Orlistat—Eructation—Omeprazole—Barrett's esophagus	0.00438	0.00772	CcSEcCtD
Orlistat—Vaginal infection—Esomeprazole—Barrett's esophagus	0.00421	0.00741	CcSEcCtD
Orlistat—Vaginal infection—Omeprazole—Barrett's esophagus	0.00421	0.00741	CcSEcCtD
Orlistat—Neoplasm—Esomeprazole—Barrett's esophagus	0.00403	0.0071	CcSEcCtD
Orlistat—Urine output increased—Esomeprazole—Barrett's esophagus	0.00403	0.0071	CcSEcCtD
Orlistat—Urine output increased—Omeprazole—Barrett's esophagus	0.00403	0.0071	CcSEcCtD
Orlistat—Neoplasm—Omeprazole—Barrett's esophagus	0.00403	0.0071	CcSEcCtD
Orlistat—PLA2G4A—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00391	0.0436	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—GAST—Barrett's esophagus	0.00386	0.043	CbGpPWpGaD
Orlistat—DAGLA—G alpha (q) signalling events—GAST—Barrett's esophagus	0.00386	0.043	CbGpPWpGaD
Orlistat—Sleep disorder—Omeprazole—Barrett's esophagus	0.00374	0.00659	CcSEcCtD
Orlistat—Sleep disorder—Esomeprazole—Barrett's esophagus	0.00374	0.00659	CcSEcCtD
Orlistat—Polyuria—Esomeprazole—Barrett's esophagus	0.00368	0.00649	CcSEcCtD
Orlistat—Polyuria—Omeprazole—Barrett's esophagus	0.00368	0.00649	CcSEcCtD
Orlistat—Hepatic failure—Omeprazole—Barrett's esophagus	0.0036	0.00634	CcSEcCtD
Orlistat—Hepatic failure—Esomeprazole—Barrett's esophagus	0.0036	0.00634	CcSEcCtD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00345	0.0385	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00345	0.0385	CbGpPWpGaD
Orlistat—Increased appetite—Esomeprazole—Barrett's esophagus	0.00344	0.00607	CcSEcCtD
Orlistat—Increased appetite—Omeprazole—Barrett's esophagus	0.00344	0.00607	CcSEcCtD
Orlistat—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.00343	0.00604	CcSEcCtD
Orlistat—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.00343	0.00604	CcSEcCtD
Orlistat—Thirst—Omeprazole—Barrett's esophagus	0.0034	0.00599	CcSEcCtD
Orlistat—Thirst—Esomeprazole—Barrett's esophagus	0.0034	0.00599	CcSEcCtD
Orlistat—Arthritis—Omeprazole—Barrett's esophagus	0.00333	0.00587	CcSEcCtD
Orlistat—Arthritis—Esomeprazole—Barrett's esophagus	0.00333	0.00587	CcSEcCtD
Orlistat—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00331	0.00584	CcSEcCtD
Orlistat—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00331	0.00584	CcSEcCtD
Orlistat—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00323	0.0057	CcSEcCtD
Orlistat—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00323	0.0057	CcSEcCtD
Orlistat—Dry skin—Esomeprazole—Barrett's esophagus	0.00296	0.00523	CcSEcCtD
Orlistat—Dry skin—Omeprazole—Barrett's esophagus	0.00296	0.00523	CcSEcCtD
Orlistat—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00295	0.00521	CcSEcCtD
Orlistat—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00295	0.00521	CcSEcCtD
Orlistat—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00294	0.00519	CcSEcCtD
Orlistat—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00294	0.00519	CcSEcCtD
Orlistat—Breast disorder—Esomeprazole—Barrett's esophagus	0.00292	0.00515	CcSEcCtD
Orlistat—Breast disorder—Omeprazole—Barrett's esophagus	0.00292	0.00515	CcSEcCtD
Orlistat—Cramp muscle—Omeprazole—Barrett's esophagus	0.00291	0.00513	CcSEcCtD
Orlistat—Cramp muscle—Esomeprazole—Barrett's esophagus	0.00291	0.00513	CcSEcCtD
Orlistat—Gastritis—Omeprazole—Barrett's esophagus	0.00286	0.00505	CcSEcCtD
Orlistat—Gastritis—Esomeprazole—Barrett's esophagus	0.00286	0.00505	CcSEcCtD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—SLC9A1—Barrett's esophagus	0.00284	0.0317	CbGpPWpGaD
Orlistat—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00281	0.00496	CcSEcCtD
Orlistat—Abdominal distension—Omeprazole—Barrett's esophagus	0.00281	0.00496	CcSEcCtD
Orlistat—Asthma—Esomeprazole—Barrett's esophagus	0.0028	0.00493	CcSEcCtD
Orlistat—Influenza—Omeprazole—Barrett's esophagus	0.0028	0.00493	CcSEcCtD
Orlistat—Asthma—Omeprazole—Barrett's esophagus	0.0028	0.00493	CcSEcCtD
Orlistat—Influenza—Esomeprazole—Barrett's esophagus	0.0028	0.00493	CcSEcCtD
Orlistat—Bronchospasm—Omeprazole—Barrett's esophagus	0.00275	0.00485	CcSEcCtD
Orlistat—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00275	0.00485	CcSEcCtD
Orlistat—Pancreatitis—Omeprazole—Barrett's esophagus	0.00274	0.00483	CcSEcCtD
Orlistat—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00274	0.00483	CcSEcCtD
Orlistat—Sweating increased—Omeprazole—Barrett's esophagus	0.00272	0.0048	CcSEcCtD
Orlistat—Sweating increased—Esomeprazole—Barrett's esophagus	0.00272	0.0048	CcSEcCtD
Orlistat—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.0026	0.00458	CcSEcCtD
Orlistat—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.0026	0.00458	CcSEcCtD
Orlistat—Infestation—Esomeprazole—Barrett's esophagus	0.00249	0.00439	CcSEcCtD
Orlistat—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00249	0.00439	CcSEcCtD
Orlistat—Infestation—Omeprazole—Barrett's esophagus	0.00249	0.00439	CcSEcCtD
Orlistat—Infestation NOS—Omeprazole—Barrett's esophagus	0.00249	0.00439	CcSEcCtD
Orlistat—Depression—Omeprazole—Barrett's esophagus	0.00249	0.00438	CcSEcCtD
Orlistat—Depression—Esomeprazole—Barrett's esophagus	0.00249	0.00438	CcSEcCtD
Orlistat—Renal failure—Omeprazole—Barrett's esophagus	0.00245	0.00432	CcSEcCtD
Orlistat—Renal failure—Esomeprazole—Barrett's esophagus	0.00245	0.00432	CcSEcCtD
Orlistat—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00242	0.00427	CcSEcCtD
Orlistat—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00242	0.00427	CcSEcCtD
Orlistat—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00236	0.00415	CcSEcCtD
Orlistat—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00236	0.00415	CcSEcCtD
Orlistat—Sinusitis—Omeprazole—Barrett's esophagus	0.00234	0.00412	CcSEcCtD
Orlistat—Sinusitis—Esomeprazole—Barrett's esophagus	0.00234	0.00412	CcSEcCtD
Orlistat—PLA2G7—Metabolism of proteins—CDX2—Barrett's esophagus	0.00226	0.0252	CbGpPWpGaD
Orlistat—Hepatitis—Omeprazole—Barrett's esophagus	0.00224	0.00394	CcSEcCtD
Orlistat—Hepatitis—Esomeprazole—Barrett's esophagus	0.00224	0.00394	CcSEcCtD
Orlistat—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00222	0.00391	CcSEcCtD
Orlistat—Pharyngitis—Omeprazole—Barrett's esophagus	0.00222	0.00391	CcSEcCtD
Orlistat—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00221	0.00389	CcSEcCtD
Orlistat—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00221	0.00389	CcSEcCtD
Orlistat—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.0022	0.00389	CcSEcCtD
Orlistat—Oedema peripheral—Omeprazole—Barrett's esophagus	0.0022	0.00389	CcSEcCtD
Orlistat—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00219	0.00387	CcSEcCtD
Orlistat—Urethral disorder—Omeprazole—Barrett's esophagus	0.00219	0.00387	CcSEcCtD
Orlistat—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00202	0.00356	CcSEcCtD
Orlistat—Immune system disorder—Omeprazole—Barrett's esophagus	0.00202	0.00356	CcSEcCtD
Orlistat—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00202	0.00355	CcSEcCtD
Orlistat—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00202	0.00355	CcSEcCtD
Orlistat—FASN—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—Barrett's esophagus	0.00201	0.0224	CbGpPWpGaD
Orlistat—Alopecia—Omeprazole—Barrett's esophagus	0.00198	0.00349	CcSEcCtD
Orlistat—Alopecia—Esomeprazole—Barrett's esophagus	0.00198	0.00349	CcSEcCtD
Orlistat—Mental disorder—Omeprazole—Barrett's esophagus	0.00196	0.00346	CcSEcCtD
Orlistat—Mental disorder—Esomeprazole—Barrett's esophagus	0.00196	0.00346	CcSEcCtD
Orlistat—CYP3A4—digestive system—Barrett's esophagus	0.00196	0.0178	CbGeAlD
Orlistat—Malnutrition—Omeprazole—Barrett's esophagus	0.00195	0.00343	CcSEcCtD
Orlistat—Malnutrition—Esomeprazole—Barrett's esophagus	0.00195	0.00343	CcSEcCtD
Orlistat—Flatulence—Esomeprazole—Barrett's esophagus	0.00192	0.00338	CcSEcCtD
Orlistat—Flatulence—Omeprazole—Barrett's esophagus	0.00192	0.00338	CcSEcCtD
Orlistat—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00191	0.00336	CcSEcCtD
Orlistat—Dysgeusia—Omeprazole—Barrett's esophagus	0.00191	0.00336	CcSEcCtD
Orlistat—Back pain—Esomeprazole—Barrett's esophagus	0.00188	0.00332	CcSEcCtD
Orlistat—Back pain—Omeprazole—Barrett's esophagus	0.00188	0.00332	CcSEcCtD
Orlistat—Muscle spasms—Omeprazole—Barrett's esophagus	0.00187	0.0033	CcSEcCtD
Orlistat—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00187	0.0033	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00184	0.0205	CbGpPWpGaD
Orlistat—Vision blurred—Esomeprazole—Barrett's esophagus	0.00184	0.00324	CcSEcCtD
Orlistat—Vision blurred—Omeprazole—Barrett's esophagus	0.00184	0.00324	CcSEcCtD
Orlistat—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.00181	0.00319	CcSEcCtD
Orlistat—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.00181	0.00319	CcSEcCtD
Orlistat—Angioedema—Omeprazole—Barrett's esophagus	0.00178	0.00314	CcSEcCtD
Orlistat—Angioedema—Esomeprazole—Barrett's esophagus	0.00178	0.00314	CcSEcCtD
Orlistat—PLA2G4A—Endothelins—SLC9A1—Barrett's esophagus	0.00178	0.0198	CbGpPWpGaD
Orlistat—FASN—SREBP signalling—PPARG—Barrett's esophagus	0.00176	0.0196	CbGpPWpGaD
Orlistat—Malaise—Esomeprazole—Barrett's esophagus	0.00176	0.0031	CcSEcCtD
Orlistat—Malaise—Omeprazole—Barrett's esophagus	0.00176	0.0031	CcSEcCtD
Orlistat—Vertigo—Omeprazole—Barrett's esophagus	0.00175	0.00308	CcSEcCtD
Orlistat—Vertigo—Esomeprazole—Barrett's esophagus	0.00175	0.00308	CcSEcCtD
Orlistat—Palpitations—Esomeprazole—Barrett's esophagus	0.00172	0.00303	CcSEcCtD
Orlistat—Palpitations—Omeprazole—Barrett's esophagus	0.00172	0.00303	CcSEcCtD
Orlistat—Cough—Esomeprazole—Barrett's esophagus	0.0017	0.003	CcSEcCtD
Orlistat—Cough—Omeprazole—Barrett's esophagus	0.0017	0.003	CcSEcCtD
Orlistat—Myalgia—Esomeprazole—Barrett's esophagus	0.00166	0.00292	CcSEcCtD
Orlistat—Chest pain—Omeprazole—Barrett's esophagus	0.00166	0.00292	CcSEcCtD
Orlistat—Myalgia—Omeprazole—Barrett's esophagus	0.00166	0.00292	CcSEcCtD
Orlistat—Chest pain—Esomeprazole—Barrett's esophagus	0.00166	0.00292	CcSEcCtD
Orlistat—Anxiety—Omeprazole—Barrett's esophagus	0.00165	0.00291	CcSEcCtD
Orlistat—Anxiety—Esomeprazole—Barrett's esophagus	0.00165	0.00291	CcSEcCtD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.00165	0.0184	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.00165	0.0184	CbGpPWpGaD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00165	0.0029	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00165	0.0029	CcSEcCtD
Orlistat—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00165	0.0184	CbGpPWpGaD
Orlistat—Discomfort—Omeprazole—Barrett's esophagus	0.00164	0.00289	CcSEcCtD
Orlistat—Discomfort—Esomeprazole—Barrett's esophagus	0.00164	0.00289	CcSEcCtD
Orlistat—Dry mouth—Esomeprazole—Barrett's esophagus	0.00162	0.00286	CcSEcCtD
Orlistat—Dry mouth—Omeprazole—Barrett's esophagus	0.00162	0.00286	CcSEcCtD
Orlistat—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00159	0.0028	CcSEcCtD
Orlistat—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00159	0.0028	CcSEcCtD
Orlistat—Infection—Omeprazole—Barrett's esophagus	0.00158	0.00278	CcSEcCtD
Orlistat—Infection—Esomeprazole—Barrett's esophagus	0.00158	0.00278	CcSEcCtD
Orlistat—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00156	0.00275	CcSEcCtD
Orlistat—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00156	0.00275	CcSEcCtD
Orlistat—Skin disorder—Omeprazole—Barrett's esophagus	0.00154	0.00272	CcSEcCtD
Orlistat—Skin disorder—Esomeprazole—Barrett's esophagus	0.00154	0.00272	CcSEcCtD
Orlistat—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00154	0.00271	CcSEcCtD
Orlistat—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00154	0.00271	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00145	0.00255	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00145	0.00255	CcSEcCtD
Orlistat—Insomnia—Omeprazole—Barrett's esophagus	0.00144	0.00253	CcSEcCtD
Orlistat—Insomnia—Esomeprazole—Barrett's esophagus	0.00144	0.00253	CcSEcCtD
Orlistat—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00143	0.00252	CcSEcCtD
Orlistat—Paraesthesia—Omeprazole—Barrett's esophagus	0.00143	0.00252	CcSEcCtD
Orlistat—Dyspepsia—Esomeprazole—Barrett's esophagus	0.0014	0.00247	CcSEcCtD
Orlistat—Dyspepsia—Omeprazole—Barrett's esophagus	0.0014	0.00247	CcSEcCtD
Orlistat—Decreased appetite—Omeprazole—Barrett's esophagus	0.00138	0.00244	CcSEcCtD
Orlistat—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00138	0.00244	CcSEcCtD
Orlistat—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00137	0.00242	CcSEcCtD
Orlistat—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00137	0.00242	CcSEcCtD
Orlistat—Fatigue—Esomeprazole—Barrett's esophagus	0.00137	0.00242	CcSEcCtD
Orlistat—Fatigue—Omeprazole—Barrett's esophagus	0.00137	0.00242	CcSEcCtD
Orlistat—Pain—Omeprazole—Barrett's esophagus	0.00136	0.0024	CcSEcCtD
Orlistat—Pain—Esomeprazole—Barrett's esophagus	0.00136	0.0024	CcSEcCtD
Orlistat—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00131	0.00231	CcSEcCtD
Orlistat—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00131	0.00231	CcSEcCtD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.0013	0.0145	CbGpPWpGaD
Orlistat—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.0013	0.00229	CcSEcCtD
Orlistat—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.0013	0.00229	CcSEcCtD
Orlistat—FASN—p73 transcription factor network—RELA—Barrett's esophagus	0.00128	0.0142	CbGpPWpGaD
Orlistat—Urticaria—Omeprazole—Barrett's esophagus	0.00126	0.00223	CcSEcCtD
Orlistat—Urticaria—Esomeprazole—Barrett's esophagus	0.00126	0.00223	CcSEcCtD
Orlistat—Body temperature increased—Omeprazole—Barrett's esophagus	0.00126	0.00221	CcSEcCtD
Orlistat—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00126	0.00221	CcSEcCtD
Orlistat—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00126	0.00221	CcSEcCtD
Orlistat—Abdominal pain—Omeprazole—Barrett's esophagus	0.00126	0.00221	CcSEcCtD
Orlistat—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00117	0.00206	CcSEcCtD
Orlistat—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00117	0.00206	CcSEcCtD
Orlistat—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.00115	0.0129	CbGpPWpGaD
Orlistat—FASN—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Barrett's esophagus	0.00115	0.0128	CbGpPWpGaD
Orlistat—Asthenia—Esomeprazole—Barrett's esophagus	0.00114	0.00201	CcSEcCtD
Orlistat—Asthenia—Omeprazole—Barrett's esophagus	0.00114	0.00201	CcSEcCtD
Orlistat—Pruritus—Omeprazole—Barrett's esophagus	0.00112	0.00198	CcSEcCtD
Orlistat—Pruritus—Esomeprazole—Barrett's esophagus	0.00112	0.00198	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—GAST—Barrett's esophagus	0.0011	0.0123	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—GAST—Barrett's esophagus	0.0011	0.0123	CbGpPWpGaD
Orlistat—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00109	0.00192	CcSEcCtD
Orlistat—Diarrhoea—Omeprazole—Barrett's esophagus	0.00109	0.00192	CcSEcCtD
Orlistat—Dizziness—Esomeprazole—Barrett's esophagus	0.00105	0.00185	CcSEcCtD
Orlistat—Dizziness—Omeprazole—Barrett's esophagus	0.00105	0.00185	CcSEcCtD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—Barrett's esophagus	0.00102	0.0114	CbGpPWpGaD
Orlistat—Vomiting—Esomeprazole—Barrett's esophagus	0.00101	0.00178	CcSEcCtD
Orlistat—Vomiting—Omeprazole—Barrett's esophagus	0.00101	0.00178	CcSEcCtD
Orlistat—Rash—Esomeprazole—Barrett's esophagus	0.001	0.00177	CcSEcCtD
Orlistat—Rash—Omeprazole—Barrett's esophagus	0.001	0.00177	CcSEcCtD
Orlistat—Dermatitis—Esomeprazole—Barrett's esophagus	0.001	0.00177	CcSEcCtD
Orlistat—Dermatitis—Omeprazole—Barrett's esophagus	0.001	0.00177	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—GAST—Barrett's esophagus	0.000998	0.0111	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—GAST—Barrett's esophagus	0.000998	0.0111	CbGpPWpGaD
Orlistat—Headache—Esomeprazole—Barrett's esophagus	0.000996	0.00176	CcSEcCtD
Orlistat—Headache—Omeprazole—Barrett's esophagus	0.000996	0.00176	CcSEcCtD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000945	0.0105	CbGpPWpGaD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000945	0.0105	CbGpPWpGaD
Orlistat—Nausea—Omeprazole—Barrett's esophagus	0.000944	0.00166	CcSEcCtD
Orlistat—Nausea—Esomeprazole—Barrett's esophagus	0.000944	0.00166	CcSEcCtD
Orlistat—DAGLB—Hemostasis—HGF—Barrett's esophagus	0.00085	0.00947	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—HGF—Barrett's esophagus	0.00085	0.00947	CbGpPWpGaD
Orlistat—FASN—AMPK Signaling—TP53—Barrett's esophagus	0.000823	0.00917	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTGES—Barrett's esophagus	0.00082	0.00915	CbGpPWpGaD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.000816	0.0091	CbGpPWpGaD
Orlistat—PLA2G4A—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000768	0.00856	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—SST—Barrett's esophagus	0.000753	0.0084	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—SST—Barrett's esophagus	0.000753	0.0084	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—SST—Barrett's esophagus	0.000684	0.00763	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—SST—Barrett's esophagus	0.000684	0.00763	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.000674	0.00751	CbGpPWpGaD
Orlistat—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000655	0.00731	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000633	0.00705	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CYP26A1—Barrett's esophagus	0.000622	0.00693	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000608	0.00678	CbGpPWpGaD
Orlistat—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.0006	0.00669	CbGpPWpGaD
Orlistat—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000592	0.0066	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—GAST—Barrett's esophagus	0.00059	0.00658	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—GAST—Barrett's esophagus	0.00059	0.00658	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGES—Barrett's esophagus	0.00058	0.00647	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000559	0.00624	CbGpPWpGaD
Orlistat—PNLIP—Disease—SLC9A1—Barrett's esophagus	0.000535	0.00597	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—GAST—Barrett's esophagus	0.000489	0.00545	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000487	0.00543	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—CXCL8—Barrett's esophagus	0.000482	0.00538	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000459	0.00512	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—SLC9A1—Barrett's esophagus	0.000448	0.005	CbGpPWpGaD
Orlistat—FASN—Metabolism—CYP26A1—Barrett's esophagus	0.00044	0.0049	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000415	0.00462	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—SST—Barrett's esophagus	0.000404	0.00451	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—SST—Barrett's esophagus	0.000404	0.00451	CbGpPWpGaD
Orlistat—FASN—Disease—SLC9A1—Barrett's esophagus	0.000379	0.00422	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000361	0.00403	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000346	0.00386	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SST—Barrett's esophagus	0.000335	0.00373	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000325	0.00362	CbGpPWpGaD
Orlistat—FASN—Metabolism—SLC9A1—Barrett's esophagus	0.000317	0.00354	CbGpPWpGaD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000311	0.00347	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000294	0.00327	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000294	0.00327	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TP53—Barrett's esophagus	0.000285	0.00318	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TP53—Barrett's esophagus	0.000285	0.00318	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000267	0.00297	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000267	0.00297	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000263	0.00293	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000258	0.00288	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000256	0.00285	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000255	0.00284	CbGpPWpGaD
Orlistat—PNLIP—Disease—APC—Barrett's esophagus	0.000253	0.00282	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—GAST—Barrett's esophagus	0.000251	0.0028	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGES—Barrett's esophagus	0.000249	0.00278	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—APC—Barrett's esophagus	0.000214	0.00238	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—APC—Barrett's esophagus	0.000214	0.00238	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—HGF—Barrett's esophagus	0.000214	0.00238	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PPARG—Barrett's esophagus	0.000205	0.00228	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTGS2—Barrett's esophagus	0.000192	0.00214	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CYP26A1—Barrett's esophagus	0.000189	0.0021	CbGpPWpGaD
Orlistat—FASN—Disease—APC—Barrett's esophagus	0.000179	0.002	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—APC—Barrett's esophagus	0.000177	0.00198	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—SST—Barrett's esophagus	0.000172	0.00192	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—RELA—Barrett's esophagus	0.000167	0.00186	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—RELA—Barrett's esophagus	0.000167	0.00186	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTGS2—Barrett's esophagus	0.000161	0.00179	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCL8—Barrett's esophagus	0.000157	0.00176	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCL8—Barrett's esophagus	0.000157	0.00176	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000156	0.00174	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GAST—Barrett's esophagus	0.000148	0.00165	CbGpPWpGaD
Orlistat—FASN—Metabolism—PPARG—Barrett's esophagus	0.000145	0.00161	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000139	0.00155	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—RELA—Barrett's esophagus	0.000138	0.00154	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—SLC9A1—Barrett's esophagus	0.000136	0.00152	CbGpPWpGaD
Orlistat—FASN—Disease—PTGS2—Barrett's esophagus	0.000136	0.00152	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCL8—Barrett's esophagus	0.00013	0.00146	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGS2—Barrett's esophagus	0.000114	0.00127	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.00011	0.00122	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SST—Barrett's esophagus	0.000102	0.00113	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TP53—Barrett's esophagus	9.66e-05	0.00108	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TP53—Barrett's esophagus	9.66e-05	0.00108	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TP53—Barrett's esophagus	8.01e-05	0.000893	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TP53—Barrett's esophagus	7.17e-05	0.0008	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL8—Barrett's esophagus	6.71e-05	0.000748	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARG—Barrett's esophagus	6.21e-05	0.000692	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGES—Barrett's esophagus	5.83e-05	0.00065	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APC—Barrett's esophagus	5.38e-05	0.0006	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS2—Barrett's esophagus	4.89e-05	0.000545	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	4.42e-05	0.000493	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RELA—Barrett's esophagus	4.2e-05	0.000469	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL8—Barrett's esophagus	3.96e-05	0.000442	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	3.19e-05	0.000355	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TP53—Barrett's esophagus	2.43e-05	0.000271	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARG—Barrett's esophagus	1.45e-05	0.000162	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.14e-05	0.000128	CbGpPWpGaD
